Last reviewed: June 30, 2026
Last updated: June 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that signals your brain to reduce hunger and regulate blood sugar levels. The medication works best when started at a low dose and gradually increased every 4 weeks, allowing your body to adjust while minimizing nausea and other common reactions. Understanding your dose pathway helps you prepare mentally and physically for your weight management journey.
How Semaglutide Injection Dosing Works
Semaglutide dosing follows a stepwise escalation pattern designed to help your system tolerate the medication safely. You begin with the lowest dose, typically 0.25 milligrams, injected once weekly under the skin. Every 4 weeks, your dose increases by one level if you're tolerating the medication well, giving your body time to adapt to the GLP-1 receptor activation.
The typical progression moves from 0.25 mg to 0.5 mg, then 1.0 mg, and finally to maintenance doses of 1.7 or 2.4 mg weekly. This careful escalation reduces the chance of overwhelming nausea or appetite suppression during your first month. Most people find that side effects improve significantly once their body adjusts, usually by week 3 or 4 at each dose level.
Starting Your Semaglutide Journey: What to Expect
Your first injection represents the beginning of a 16 to 20-week program before reaching a maintenance dose. During this initial phase, you'll keep a simple log of how you feel—your hunger levels, energy, and any nausea—to share with your PlexusDx provider. This data helps your clinician decide whether to advance your dose on schedule or give your body an extra week at your current level.
Most people lose between 5 to 10 pounds in the first month, though this varies widely based on your starting weight, diet, and exercise habits. The appetite suppression from semaglutide typically peaks 2 to 3 days after injection, so planning lighter meals around that window helps you stay comfortable. Staying hydrated and eating protein-rich foods during your dose escalation period supports your body's adjustment and stabilizes blood sugar.
Personalizing Your Dose With Genetic Insights
Not everyone responds identically to semaglutide because your genetic makeup influences how strongly you activate GLP-1 receptors. The PlexusDx Precision Peptide Genetic Test examines key variants like GLP1R rs6923761 and GIPR rs1800437 to reveal your peptide-pathway predispositions. This science-backed approach helps your clinician predict whether you may need a lower dose for optimal results or benefit from advancing faster to your target dose.
Your genetic insights also map 14 metabolic pathways and 150+ peptide-related markers that affect hunger hormones, satiety signaling, and fat storage. Patients who know their genetic profile report feeling more confident in their treatment plan because dosing decisions are based on your biology, not just standard protocols. Adding the Precision Peptide Genetic Test for $99 after your first month of treatment transforms your semaglutide experience from guesswork into personalized precision.
Managing Side Effects During Dose Increases
Nausea is the most common side effect during the first 2 to 4 weeks of semaglutide therapy, affecting roughly 25% to 40% of patients to some degree. This typically fades as your body adjusts, but eating smaller meals, avoiding high-fat foods, and staying hydrated significantly reduce symptoms. If nausea persists beyond week 4 at your current dose, your PlexusDx provider can pause your dose escalation for an extra week, allowing complete adjustment before moving forward.
Constipation may develop during semaglutide use because the medication slows gastric emptying and reduces overall food intake. Increasing fiber gradually through vegetables, whole grains, and legumes—rather than supplements alone—helps prevent discomfort. Staying active with light walking after meals and drinking at least 8 glasses of water daily supports healthy digestion throughout your treatment. Always report persistent side effects to your clinician; they can adjust your timeline or suggest safe, evidence-based remedies.
Cost and Access to Semaglutide Injections
PlexusDx compounded semaglutide injections start at $149 per month across all commitment tiers, with no insurance required and no membership fees. All medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and potency regardless of your dose level. Payments are HSA and FSA eligible, giving you the option to use tax-advantaged health savings if available through your employer or self-employment plan.
Your dose may increase over 16 to 20 weeks, but your price won't—that's the PlexusDx commitment to transparent, predictable costs. You'll receive your weekly injections by mail, with support from your dedicated clinician who monitors your progress and adjusts your protocol as needed. If you decide compounded semaglutide is the right fit, PlexusDx serves all 50 states and can get you started within 24 to 48 hours of approval.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide, and why so low?
The standard starting dose is 0.25 milligrams injected once weekly. This low dose minimizes nausea and allows your GLP-1 receptors to activate gradually without overwhelming your digestive system. Starting low ensures you can tolerate the medication and experience its appetite-suppressing benefits as your dose increases over 4-week intervals.
How long does it take to reach the full semaglutide dose?
Most people reach their maintenance dose of 1.7 or 2.4 mg within 16 to 20 weeks, assuming they advance their dose every 4 weeks as tolerated. If you experience significant side effects or prefer a slower pace, your PlexusDx provider can extend your timeline. The goal is finding your optimal dose—the level where you feel satisfied with food, have steady energy, and experience minimal nausea.
Can I skip a dose increase if I'm losing weight well at my current dose?
Yes, absolutely. Your PlexusDx clinician can pause your escalation indefinitely if you're achieving your weight loss goals and feeling well. Some patients plateau at 0.5 or 1.0 mg and see excellent results without advancing further. Your dose should reflect your personal needs and comfort, not a rigid schedule.
Is compounded semaglutide as safe as brand-name Wegovy?
PlexusDx compounded semaglutide comes from licensed 503A compounding pharmacies that meet strict FDA and state pharmacy board standards for purity and potency. While compounded medications are not FDA-approved as brand formulations, the semaglutide compound itself is a well-studied molecule with decades of clinical evidence. Your clinician monitors your response just as carefully as with any other treatment.
How does the Precision Peptide Genetic Test help with my semaglutide dosing?
The test examines your GLP1R and GIPR gene variants to reveal how strongly you respond to semaglutide at standard doses. If your results show a variant linked to stronger GLP-1 signaling, your provider may recommend a slower dose escalation to avoid side effects. Conversely, if your genetics suggest weaker receptor activation, your clinician can plan a faster titration schedule to reach your therapeutic dose sooner.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Zepbound and Wegovy: Can You Take Them Together for Weight Loss?
Navigating Weight Management: Can 17-Year-Olds Take Ozempic?